GMP for Blood Products

For the second time, Iranian Blood Transfusion Organization (IBTO) was selected as the World Health Organization’s representative in Eastern Mediterranean Region Office (EMRO) and cooperation in the field of good manufacturing practices (GMP) for blood products will start from the second half of 2017, said Dr Yetmgeta Abdella, technical officer at WHO’s Blood Transfusion Safety office, on Saturday. Last week, he visited Iran to attend the two-day GMP workshop at the IBTO which is located in Tehran’s Vesal Street, IRNA reported. He expressed hope that the IBTO could also be at the forefront of research and educational activities. According to WHO, implementation and enforcement of GMP in blood and plasma collection is considered a priority as a tool to minimize the risk of transmitting currently known and emerging blood-borne diseases. A number of educational programs and training workshops are being jointly developed by the WHO and its regional offices, to meet the needs in blood transfusion safety.